Ensign Peak Advisors
WVE icon

Ensign Peak Advisors’s Wave Life Sciences WVE Stock Holding History

Ensign Peak Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-313,307
Closed -$2.29M – 1732
2025
Q3 		$2.29M Hold
313,307
– – ﹤0.01% 767
2025
Q2 		$2.04M Buy
+313,307
New +$2.07M ﹤0.01% 904

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Ensign Peak Advisors's WVE Position: Q4 2025 in Review

Ensign Peak Advisors sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 313,307 shares — an estimated $2.29M sold.

Ensign Peak Advisors first reported a position in WVE in Q2 2025 and held it in 2 quarters. The position peaked at $2.29M in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Ensign Peak Advisors reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 313,307 Wave Life Sciences shares in Q4 2025, an estimated $2.29M.
  • Ensign Peak Advisors first reported a position in Wave Life Sciences in Q2 2025 and held it in 2 quarters.
  • Ensign Peak Advisors's Wave Life Sciences position peaked at $2.29M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.